Video Shorts

Orals vs. Injectors - The Future of Weight Loss Maintenance

The Five Elements of AI Success in Large Enterprises

Leaving Pharma for AI

Biotech IPO Window: Will Enthusiasm Return in 2026

Why Clinical Trials Fail and How to Fix Them

#1: Pharma’s Finest

#2: AI’s Ascent

#3: Pharma 50 Milestone

#4: The DTC Revolution

#5: Market Access Reimagined

#6: Pricing and Policy

#7: Emerging Pharma Leaders

#8: State of Industry Survey

#9: Complete Response Letters

#10: Drug Pipeline Report

The Power of Automation

AI Agents in Pharmacy

The Rise of Oral GLP-1's

The Impact of FDA's Approval of Papzimeos

The Hidden Cost of Unmanaged Kidney Disease Complications

How the DSCSA is Accelerating Digital Transformation

The GLP-1 Shift to Mass Market

FDA's Priority Voucher Review Program's Impact on Timelines

Why Platform Technologies are Essential for Biotech Investors

Why Upfront Molecular Testing is the Future of Systemic Therapy

Strategizing for Growth in 2025

Balancing Innovation and Capital

AI's Recent Advancements in the Pharmaceutical Industry

Fixing Drug Supply Chains

Approaching Inclusivity and Representation in the Development and Communication of Biomarker-Driven Diagnostics